Synthesis and biological activities of 5-thio-α-GALCERS

ACS Medicinal Chemistry Letters

Volumn 6, Issue 4, 2015, Pages 476-480

  Bi, Jingjing ^a,b   Wang, Jing ^c   Zhou, Kai ^c   Wang, Yuancheng ^a   Fang, Min ^c   Du, Yuguo ^a,b  

^a RESEARCH CENTER FOR ECO ENVIRONMENTAL SCIENCES   (China)

^b JIANGXI NORMAL UNIVERSITY   (China)

^c INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

5 thio GalCer; antitumor activity; iNKT cells; KRN7000

Indexed keywords

1 O (ALPHA GALACTOPYRANOSYL) 2 HEXACOSANOYLAMINO 1,3,4 OCTADECANETRIOL; 5 THIO 1 O (ALPHA GALACTOPYRANOSYL) 2 HEXACOSANOYLAMINO 1,3,4 OCTADECANETRIOL; 5 THIO ALPHA GALACTOSYLCERAMIDE 566; ALPHA GALACTOSYLCERAMIDE; ANTINEOPLASTIC AGENT; CD1D ANTIGEN; GAMMA INTERFERON; IMMUNOSTIMULATING AGENT; INTERLEUKIN 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG SYNTHESIS; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; TH1 CELL;

EID: 84927621701     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/acsmedchemlett.5b00046     Document Type: Article

References (49)

1. Bendelac, A.; Savage, P. B.; Teyton, L. The biology of NKT cells Annu. Rev. Immunol. 2007, 25, 297-336
2. Hong, C.; Park, S.-H. Application of natural killer T cells in antitumor immunotherapy Crit. Rev. Immun. 2007, 27, 511-525
3. Motohashi, S.; Nakayama, T. Clinical applications of natural killer T cell-based immunotherapy for cancer Cancer Sci. 2008, 99, 638-645
4. Berzofsky, J. A.; Terabe, M. The contrasting roles of NKT cells in tumor immunity Curr. Mol. Med. 2009, 9, 667-672
5. Behar, S. M.; Porcelli, S. A. CD1-restricted T cells in host defense to infectious diseases Curr. Top. Microbiol. Immun. 2007, 314, 215-250
6. Tupin, E.; Kinjo, Y.; Kronenberg, M. The unique role of natural killer T cells in the response to microorganisms Nat. Rev. Microbiol. 2007, 5, 405-417
7. Natori, T.; Morita, M.; Akimoto, K.; Koezuka, Y. Agelasphins, novel antitumor and immunostimulatory cerebrosides from the marine sponge Agelas mauritianus Tetrahedron 1994, 50, 2771-2784
8. Crowe, N. Y.; Uldrich, A. P.; Kyparissoudis, K.; Hammond, K. J. L.; Hayakawa, Y.; Sidobre, S.; Keating, R.; Kronenberg, M.; Smyth, M. J.; Godfrey, D. I. Glycolipid antigen drives rapid expansion and sustained cytokine production by NKT cells J. Immunol. 2003, 171, 4020-4027
9. Carnaud, C.; Lee, D.; Donnars, O.; Park, S.-H.; Beavis, A.; Koezuka, Y.; Bendelac, A. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells J. Immunol. 1999, 163, 4647-4650
10. Godfrey, D. I.; MacDonald, H. R.; Kronenberg, M.; Smyth, M. J.; VanKaer, L. NKT cells: what's in a name? Nat. Rev. Immunol. 2004, 4, 231-237
11. Gonzalez-Aseguinolaza, G.; VanKaer, L.; Bergmann, C. C.; Wilson, J. M.; Schmieg, J.; Kronenberg, M.; Nakayama, T.; Taniguchi, M.; Koezuka, Y.; Tsuji, M. Natural killer T cell ligand α-galactosylceramide enhances protective immunity induced by malaria vaccines J. Exp. Med. 2002, 195, 617-624
12. Miyamoto, K.; Miyake, S.; Yamamura, T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing Th2 bias of natural killer T cells Nature 2001, 413, 531-534
13. Morita, M.; Motoki, K.; Akimoto, K.; Natori, T.; Sakai, T.; Sawa, E.; Yamaji, K.; Koezuka, Y.; Kobayashi, E.; Fukushima, H. Structure-activity relationship of α-galactosylceramides against B16-bearing mice J. Med. Chem. 1995, 38, 2176-2187
14. Takeda, K.; Hayakawa, Y.; Van Kaer, L.; Matsuda, H.; Yagita, H.; Okumura, K. Critical contribution of liver natural killer T cells to a murine model of hepatitis Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 5498-5530
15. Hayakawa, Y.; Rovero, S.; Forni, G.; Smyth, M. J. α-galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 9464-9469
16. Chang, D. H.; Osman, K.; Connolly, J.; Kukreja, A.; Krasovsky, J.; Pack, M.; Hutchinson, A.; Geller, M.; Liu, N.; Annable, R.; Shay, J.; Kirchhoff, K.; Nishi, N.; Ando, Y.; Hayashi, K.; Hassoun, H.; Steinman, R. M.; Dhodapkar, M. V. Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients J. Exp. Med. 2005, 201, 1503-1517
17. Uchida, T.; Horiguchi, S.; Tanaka, Y.; Yamamoto, H.; Kunii, N.; Motohashi, S.; Taniguchi, M.; Nakayama, T.; Okamoto, Y. Phase I study of α-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer Cancer Immunol. Immun. 2008, 57, 337-345
18. Ko, S. Y.; Ko, H. J.; Chang, W. S.; Park, S. H.; Kweon, M. N.; Kang, C. Y. α-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor J. Immunol. 2005, 175, 3309-3317
19. Kaer, L. V. α-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles Nat. Rev. Immunol. 2005, 5, 31-42
20. Sharif, S.; Arreaza, G. A.; Zucker, P.; Mi, Q.-S.; Sondhi, J.; Naidenko, O. V.; Kronenberg, M.; Koezuka, Y.; Delovitch, T. L.; Gombert, J.-M.; Leite-de-Moraes, M.; Gouarin, C.; Zhu, R.; Hameg, A.; Nakayama, T.; Taniguchi, M.; Lepault, F.; Lehuen, A.; Bach, J.-F.; Herbelin, A. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes Nat. Med. 2001, 7, 1057-1062
21. Burdin, N.; Brossay, L.; Kronenberg, M. Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis Eur. J. Immunol. 1999, 29, 2014-2025
22. Berkers, C. R.; Ovaa, H. Immunotherapeutic potential for ceramide-based activators of iNKT cells Trends Pharmacol. Sci. 2005, 26, 252-257
23. Banchet-Cadeddu, A.; Henon, E.; Dauchez, M.; Renault, J.-H.; Monneaux, F.; Haudrechy, A. The stimulating adventure of KRN 7000 Org. Biomol. Chem. 2011, 9, 3080-3104
24. Tashiro, T. Structure-activity relationship studies of novel glycosphingolipids that stimulate natural killer T-cells Biosci. Biotechnol. Biochem. 2012, 76, 1055-1067
25. Baek, D. J.; Seo, J. H.; Lim, C.; Kim, J. H.; Chung, D. H.; Cho, W. J.; Kang, C. Y.; Kim, S. The 3-deoxy analogue of α-GalCer: disclosing the role of the 4-hydroxyl group for CD1d-mediated NKT cell activation ACS Med. Chem. Lett. 2011, 2, 544-548
26. Kim, Y.; Kim, J.; Oh, K.; Lee, D. S.; Park, S. B. Heteroaromatic moieties in the sphingosine backbone of α-galactosylceramides for noncovalent interactions with CD1d ACS Med. Chem. Lett. 2012, 3, 151-154
27. Lim, C.; Kim, J. H.; Baek, D. J.; Lee, J. Y.; Cho, M.; Lee, Y. S.; Kang, C. Y.; Chung, D. H.; Cho, W. J.; Kim, S. Design and evaluation of ω-hydroxy fatty acids containing α-GalCer analogues for CD1d-mediated NKT cell activation ACS Med. Chem. Lett. 2014, 5, 331-335
28. Chang, Y. J.; Huang, J. R.; Tsai, Y. C.; Hung, J. T.; Wu, D.; Fujio, M.; Wong, C. H.; Yu, A. L. Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 10299-10304
29. Brossay, L.; Naidenko, O.; Burdin, N.; Matsuda, J.; Sakai, T.; Kronenberg, M. Cutting edge: structural requirements for galactosylceramide recognition by CD1-restricted NK T cells J. Immunol. 1998, 161, 5124-5128
30. Goff, R. D.; Gao, Y.; Mattner, J.; Zhou, D.; Yin, N.; Cantu, C., III; Teyton, L.; Bendelac, A.; Savage, P. B. Effects of lipid chain lengths in α-galactosylceramides on cytokine release by natural killer T cells J. Am. Chem. Soc. 2004, 126, 13602-13603
31. Yang, G.; Schmieg, J.; Tsuji, M.; Franck, R. W. The C-glycoside analogue of the immunostimulant α-galactosylceramide (KRN7000): synthesis and striking enhancement of activity Angew. Chem., Int. Ed. 2004, 43, 3818-3822
32. Franck, R. W.; Tsuji, M. α-C-galactosylceramides: synthesis and immunology Acc. Chem. Res. 2006, 39, 692-701
33. Patel, O.; Cameron, G.; Pellicci, D. G.; Liu, Z.; Byun, H.-S.; Beddoe, T.; McCluskey, J.; Franck, R. W.; Castaño, A. R.; Harrak, Y.; Llebaria, A.; Bittman, R.; Porcelli, S. A.; Godfrey, D. I.; Rossjohn, J. NKT TCR recognition of CD1d-α-C-galactosylceramide J. Immunol. 2011, 187, 4705-4713
34. Dere, R. T.; Zhu, X. The first synthesis of a thioglycoside analogue of the immunostimulant KRN7000 Org. Lett. 2008, 10, 4641-4644
35. Blauvelt, M. L.; Khalili, M.; Jaung, W.; Paulsen, J.; Anderson, A. C.; Wilson, S. B.; Howell, A. R. α-S-GalCer: synthesis and evaluation for iNKT cell stimulation Bioorg. Med. Chem. Lett. 2008, 18, 6374-6376
36. Hogan, A. E.; OReilly, V.; Dunne, M. R.; Dere, R. T.; Zeng, S. G.; OBrien, C.; Amu, S.; Fallon, P. G.; Exley, M. A.; OFarrelly, C.; Zhu, X.; Doherty, D. G. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide Clin. Immunol. 2011, 140, 196-207
37. Xie, W.; Tanabe, G.; Akaki, J.; Morikawa, T.; Ninomiya, K.; Minematsu, T.; Yoshikawa, M.; Wu, X.; Muraoka, O. Isolation, structure identification and SAR studies on thiosugar sulfonium salts, neosalaprinol and neoponkoranol, as potent α-glucosidase inhibitors Bioorg. Med. Chem. 2011, 19, 2015-2022
38. Capon, R. J.; MacLeod, J. K. 5-Thio-D-mannose from the marine sponge Clathria pyramida (Lendenfeld). The first example of a naturally occurring 5-thiosugar J. Chem. Soc., Chem. Commun. 1987, 15, 1200-1201
39. Matsuda, H.; Ohara, K.; Morii, Y.; Hashimoto, M.; Miyairi, K.; Okuno, T. α-Selective glycosylation with 5-thioglucopyranosyl donors; synthesis of an IsoMaltotetraoside mimic composed of 5-thioglucopyranose units Bioorg. Med. Chem. Lett. 2003, 13, 1063-1066
40. Izumi, M.; Suhara, Y.; Ichikawa, Y. Design and synthesis of potential inhibitors of Golgi endo-α-mannosidase: 5-thio-D-glucopyranosyl-α(1→3)-1-deoxymannojirimycin and methyl 5-thio-D-glucopyranosyl-α(1→3)-5-thio-α-D-mannopyranoside J. Org. Chem. 1998, 63, 4811-4816
41. Yuasa, H.; Hindsgaul, O.; Palcic, M. Chemical-enzymic synthesis of 5′-thio-N-acetyllactosamine: the first disaccharide with sulfur in the ring of the non-reducing sugar J. Am. Chem. Soc. 1992, 114, 5891-5892
42. Mehta, S.; Jordan, K. L.; Weimar, T.; Kreis, U. C.; Batchelor, R. J.; Einstein, F. W. B.; Pinto, B. M. Synthesis of sulfur analogues of methyl and allyl kojibiosides and methyl isomaltoside and conformational analysis of the kojibiosides Tetrahedron: Asymmetry 1994, 5, 2367-2396
43. Mehta, S.; Andrews, J. S.; Johnston, B. D.; Svensson, B.; Pinto, B. M. Synthesis and enzymic activity of novel glycosidase inhibitors containing sulfur and selenium J. Am. Chem. Soc. 1995, 117, 9783-9790
44. Izumi, M.; Tsuruta, O.; Harayama, S.; Hashimoto, H. Synthesis of 5-thio-L-fucose-containing disaccharides, as sequence-specific inhibitors, and 2′-fucosyllactose, as a substrate of α-L-fucosidases J. Org. Chem. 1997, 62, 992-998
45. Song, S.; Lee, T.; Jung, S.; Kim, D. Practical synthesis of KRN7000 from phytosphingosine Synthesis 2004, 6, 847-850
46. Wang, Y.; Du, Y. Synthesis of 5-thio-D-galactopyranose J. Carbohydr. Chem. 2013, 32, 240-248
47. Sim, M. M.; Kondo, H.; Wong, C. H. Synthesis of dibenzyl glycosyl phosphites using dibenzyl N,N-diethylphosphoramidite as phosphitylating reagent: an effective route to glycosyl phosphates, nucleotides, and glycosides J. Am. Chem. Soc. 1993, 115, 2260-2267
48. Pál, E.; Tabira, T.; Kawano, T.; Taniguchi, M.; Miyake, S.; Yamamura, T. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of Vα14 NK T cells J. Immunol. 2001, 166, 662-668
49. Amel-Kashipaz, M. R.; Huggins, M. L.; Lanyon, P.; Robins, A.; Todd, I.; Powell, R. J. Quantitative and Qualitative Analysis of the Balance Between Type 1 and Type 2 Cytokine-producing CD8- and CD8+ T Cells in Systemic Lupus Erythematosus J. Autoimmun. 2001, 17, 155-163